Martin Hoglund

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

A human pan-disease blood atlas of the circulating proteome.

A human pan-disease blood atlas of the circulating proteome.

Journal: Science (New York, N.Y.)

Published: October 09, 2025

Transparent Wood for Passive Radiative Cooling of Solar Absorbers.

Transparent Wood for Passive Radiative Cooling of Solar Absorbers.

Journal: Nano letters

Published: September 11, 2025

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden.

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden.

Journal: EJHaem

Published: May 11, 2025

Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML-A Population-Based Study.

Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML-A Population-Based Study.

Journal: European journal of haematology

Published: April 23, 2025

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

Journal: Nature

Published: February 28, 2025

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 17, 2024

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data.

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data.

Journal: Leukemia & lymphoma

Published: June 11, 2024

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.

Journal: Bone marrow transplantation

Published: April 11, 2024

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

Journal: American journal of hematology

Published: February 29, 2024

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis.

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis.

Journal: The Journal of molecular diagnostics : JMD

Published: February 13, 2024

Transparent Wood Biocomposite of Well-Dispersed Dye Content for Fluorescence and Lasing Applications.

Transparent Wood Biocomposite of Well-Dispersed Dye Content for Fluorescence and Lasing Applications.

Journal: ACS applied optical materials

Published: March 15, 2023

The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.

The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.

Journal: Leukemia

Published: January 24, 2023

Showing 1-12 of 104

Last Updated: 09/26/2026